Daxor Corporation (NASDAQ: DXR)
$9.02
-0.1800 ( -1.96% ) 0.2K
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
Market Data
Open
$9.02
Previous close
$9.20
Volume
0.2K
Market cap
$44.50M
Day range
$8.91 - $9.31
52 week range
$7.11 - $10.15
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| def | Proxies and info statements | 1 | Jun 21, 2024 |
| 8-k | 8K-related | 13 | Jun 05, 2024 |
| nport-p | Other | 1 | May 30, 2024 |
| 4 | Insider transactions | 1 | Mar 27, 2024 |
| 8-k | 8K-related | 15 | Mar 25, 2024 |
| n-csr/a | Other | 3 | Mar 19, 2024 |
| n-csr | Other | 5 | Mar 15, 2024 |
| n-cen | Other | 2 | Mar 15, 2024 |
| nt-ncsr/a | Quarterly Reports | 1 | Mar 08, 2024 |
| 4 | Insider transactions | 1 | Mar 06, 2024 |